Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment.
McClean, Siobhán
Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment. [electronic resource] - Human vaccines & immunotherapeutics 12 2016 - 3103-3106 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2164-554X
10.1080/21645515.2016.1216287 doi
Allergy and Immunology--trends
Antigens--immunology
Clinical Trials as Topic
Humans
Technology, Pharmaceutical--trends
Vaccines, Subunit--immunology
Prospects for subunit vaccines: Technology advances resulting in efficacious antigens requires matching advances in early clinical trial investment. [electronic resource] - Human vaccines & immunotherapeutics 12 2016 - 3103-3106 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2164-554X
10.1080/21645515.2016.1216287 doi
Allergy and Immunology--trends
Antigens--immunology
Clinical Trials as Topic
Humans
Technology, Pharmaceutical--trends
Vaccines, Subunit--immunology